Barclays’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.6M | Buy |
|
|||||
|
2025
Q1 | $9.85M | Buy |
|
|||||
|
2024
Q4 | $17.2M | Buy |
|
|||||
|
2024
Q3 | $9.8M | Sell |
|
|||||
|
2024
Q2 | $16.3M | Buy |
|
|||||
|
2024
Q1 | $1.76M | Buy |
|
|||||
|
2023
Q4 | $1.47M | Sell |
|
|||||
|
2023
Q3 | $1.75M | Buy |
|
|||||
|
2023
Q2 | $1.62M | Sell |
|
|||||
|
2023
Q1 | $4.09M | Buy |
|
|||||
|
2022
Q4 | $3.92M | Sell |
|
|||||
|
2022
Q3 | $4.86M | Sell |
|
|||||
|
2022
Q2 | $6.61M | Buy |
|
|||||
|
2022
Q1 | $12.3M | Buy |
|
|||||
|
2021
Q4 | $15.4M | Sell |
|
|||||
|
2021
Q3 | $15.1M | Buy |
|
|||||
|
2021
Q2 | $11.7M | Sell |
|
|||||
|
2021
Q1 | $11.6M | Buy |
|
|||||
|
2020
Q4 | $9.19M | Buy |
|
|||||
|
2020
Q3 | $9.74M | Sell |
|
|||||
|
2020
Q2 | $10M | Buy |
|
|||||
|
2020
Q1 | $1.35M | Sell |
|
|||||
|
2019
Q4 | $5.88M | Buy |
|
|||||
|
2019
Q3 | $2.02M | Sell |
|
|||||
|
2019
Q2 | $2.87M | Buy |
|
|||||
|
2019
Q1 | $2.26M | Sell |
|
|||||
|
2018
Q4 | $1.58M | Sell |
|
|||||
|
2018
Q3 | $3.87M | Buy |
|
|||||
|
2018
Q2 | $1.27M | Buy |
|
|||||
|
2018
Q1 | $234K | Buy |
|
|||||
|
2017
Q4 | $63K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $11K | Sell |
|
|||||
|
2017
Q1 | $38K | Buy |
|
|||||
|
2016
Q4 | $0 | Sell |
|
|||||
|
2016
Q3 | $1K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $38K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $1K | Sell |
|
|||||
|
2015
Q2 | $3K | Buy |
|
|||||
|
2015
Q1 | $4K | Sell |
|
|||||
|
2014
Q4 | $8K | Sell |
|
|||||
|
2014
Q3 | $16K | Buy |
|
|||||
|
2014
Q2 | $2K | Sell |
|
|||||
|
2014
Q1 | $8K | Sell |
|
|||||
|
2013
Q4 | $11K | Buy |
|